MyPad - Intelligent Bladder Pre-void Alerting System

Sponsor
Lancashire Teaching Hospitals NHS Foundation Trust (Other)
Overall Status
Recruiting
CT.gov ID
NCT04280887
Collaborator
University of Central Lancashire (Other)
10
1
1
45.9
0.2

Study Details

Study Description

Brief Summary

Development a 'dry alarm' that can help children and adolescents become dry at night.

Condition or Disease Intervention/Treatment Phase
  • Device: MyPad
N/A

Detailed Description

Enuresis / Bedwetting is a common problem causing much emotional distress. Most children are dry by the age of 5 years, but a significant number of older children still wet their bed. This can be very distressing for child and family. There is also an associated cost due to extra laundry and impact of lost sleep.

Programmes to help children become dry at night often include the use of a moisture alarm. The alarms sound when the child begins to wet the bed, waking them up to go to the toilet instead. Most alarms work by detecting wetness, sounding the alarm when the child starts to pass urine. As such, they still need to change pyjamas and bed sheets.

The investigators aim to develop a 'dry alarm' that can help children and adolescents become dry at night. The alarm will sound when the bladder is full, before the child passes urine. This would avoid wet beds. The investigators have engineered parts for this alarm, but need to work on making it ready for use. This device will enable children to have dry nights whilst learning bladder control.

This study has several phases. The alarm will consist of a small box worn over the abdomen. The aim is to test this overnight, and adjust it for comfort and ease. The device uses a mini ultrasound machine, which measures how much urine is in the bladder. There will be a series of tests to calibrate the device compared to a clinical ultrasound device. Then children with enuresis/ bed wetting will wear it overnight. It will be linked to an alarm which will sound once the bladder is full.

This particular study will determine the feasibility of the product, to confirm the design and specifications, including a comfort trial, calibration and comparison with clinical scans, and operating process prior to a future clinical trial.

The total number of participants is 25 - however this will be split over the different phases of the trial.

Comfort Trial - 5 Calibration trial 3 month testing phase - 10

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
CohortCohort
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
MyPad - Intelligent Bladder Pre-void Alerting System
Actual Study Start Date :
Aug 3, 2018
Anticipated Primary Completion Date :
May 31, 2022
Anticipated Study Completion Date :
May 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Participants will wear the device for the specified test period (3 months)

Device: MyPad
Ultrasound bed wetting alarm

Outcome Measures

Primary Outcome Measures

  1. Bladder expansion [3 months]

    Bladder size measurements, device is able to provide consistent readings

  2. Reduction in adverse events [3 months]

    Number of adverse events measured over the three months - reduction over time

Secondary Outcome Measures

  1. Comfort [3 months]

    Comfort, design and tolerability of device using validated comfort tool

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 7 years to 12 years

  • Bedwetting twice a week or more

  • Good understanding of English language

  • For the initial comfort trials and the calibration trial healthy volunteers may be invited to take part.

Exclusion Criteria:
  • there is a medical cause for bedwetting

  • they have significant learning difficulties

  • they are obese (above 98th centile for Body Mass Index)

  • they have severe hearing impairment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lancashire Teaching Hospitals NHS Foundation Trust Preston United Kingdom

Sponsors and Collaborators

  • Lancashire Teaching Hospitals NHS Foundation Trust
  • University of Central Lancashire

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Lancashire Teaching Hospitals NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT04280887
Other Study ID Numbers:
  • My Pad Protocol version 1
First Posted:
Feb 21, 2020
Last Update Posted:
Feb 7, 2022
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 7, 2022